Comprehensive Cancer Centers looks at myths that persist regarding prostate cancer and provides factual details to dispel them to drive increased screenings for men.
Prostate cancer is one of the most common cancers diagnosed in men by Comprehensive Cancer Centers, yet it is surrounded by a persistent cloud of misinformation, fear, and misunderstanding. These myths can have dangerous consequences, preventing men from seeking timely screenings, making informed decisions about their health, or having open conversations with their doctors and loved ones.
The silence and stigma often associated with men’s health and prostate health issues only serve to strengthen these misconceptions. To empower men to take control of their health, it is essential to confront these prostate cancer myths directly with facts and clarity. This guide will systematically debunk the most prevalent myths about prostate cancer, offering evidence-based information to replace fiction with fact.
Myth 1: Prostate Cancer is an “Old Man’s Disease”
Perhaps the most pervasive myth is that prostate cancer is a condition that only affects men in their twilight years. While it is true that the risk of developing prostate cancer increases significantly with age—with the majority of diagnoses occurring in men over 65—this statistic paints an incomplete and misleading picture. The reality is that prostate cancer can and does affect younger men. Thousands of men in their 40s and 50s are diagnosed each year, and these cases are often more aggressive and dangerous than those found in older men.
Several prostate cancer risk factors can increase a man’s risk at a younger age. A strong family history of prostate cancer is one of the most significant. A man whose father or brother had prostate cancer is more than twice as likely to develop the disease himself. If the cancer was diagnosed in a close relative before the age of 65, the risk is even higher. Race is another critical factor; for reasons that are still being researched, men of African descent are disproportionately affected. They are more likely to be diagnosed with prostate cancer, often at an earlier age, and are more than twice as likely to die from the disease compared to white men.
Dismissing prostate cancer as an “old man’s disease” is a dangerous oversimplification. It can lead younger men to ignore potential warning signs and delay conversations about screening with their doctors. The American Cancer Society recommends that men at high risk—including African American men and those with a first-degree relative diagnosed before age 65—should begin discussing screening with their doctors as early as age 40 or 45. For men at average risk, this conversation should begin at age 50. Age is a risk factor, but it is not the only one, and proactive health management should not be postponed until retirement.
Myth 2: No Symptoms Means No Cancer
Another common and dangerous belief is that if a man feels healthy and has no urinary or sexual problems, he cannot have prostate cancer. This is fundamentally untrue. Prostate Cancer Can Be Symptom-Free in Early Stages.
It grows silently within the prostate gland, often for years, without causing any noticeable changes. By the time symptoms do appear, the cancer may have already grown large enough to press on the urethra or may have spread beyond the prostate—a stage where it is much more difficult to cure.
The symptoms often associated with prostate cancer—such as a frequent urge to urinate, a weak urine stream, difficulty starting or stopping urination, or blood in the urine or semen—are more commonly caused by benign conditions. The most frequent culprit is Benign Prostatic Hyperplasia (BPH), a non-cancerous enlargement of the prostate that affects most men as they age. While these symptoms should always be evaluated by a doctor, their absence is not a clean bill of health.
This is precisely why screening is so crucial. The goal of screening, through the Prostate-Specific Antigen (PSA) blood test and the Digital Rectal Exam (DRE), is to detect the cancer before it has a chance to cause symptoms. Relying on symptoms as a trigger for a check-up is a reactive, not proactive, approach to health and can mean missing the critical window for early detection and cure.
Myth 3: A High PSA Score Means I Have Cancer
The PSA test has become a source of great confusion and anxiety for many men. A common misconception is that it is a direct “cancer test” and that a high reading is a definitive diagnosis. This is incorrect. Prostate-Specific Antigen is a protein produced by cells in the prostate gland, both normal and cancerous cells. The PSA test simply measures the level of this protein in the blood.
While prostate cancer can cause PSA levels to rise, so can several other benign conditions. BPH, prostatitis (inflammation or infection of the prostate), a recent urinary tract infection, and even recent sexual activity or vigorous exercise like cycling can temporarily elevate PSA levels. A high PSA score is simply an indicator that something may be wrong with the prostate, warranting further investigation. It is a red flag, not a diagnosis.
The only way to definitively diagnose prostate cancer is with a prostate biopsy, where small tissue samples are removed from the prostate with a needle and examined under a microscope. Doctors consider many factors beyond a single PSA number when recommending a biopsy, including a man’s age, family history, race, the results of a DRE, and, importantly, the trend of his PSA levels over time (known as PSA velocity). A slowly rising PSA is more concerning than a single, isolated high reading.
Myth 4: A Prostate Cancer Diagnosis is a Grim Diagnosis
Hearing the word “cancer” is terrifying, and many men immediately assume the worst upon receiving a prostate cancer diagnosis. However, this fatalistic view is not supported by statistics. The vast majority of prostate cancers are slow-growing and, when detected early while still confined to the prostate gland, are highly treatable and curable.
According to the American Cancer Society, the 5-year relative prostate cancer survival rate for men with local or regional prostate cancer is nearly 100%. The 15-year survival rate is 95%. This means that most men diagnosed with early-stage prostate cancer will not die from the disease. Many will live for decades and ultimately die from other, unrelated causes.
This high survival rate is a testament to the effectiveness of modern treatments and the success of early detection through screening. For many men with low-risk, slow-growing tumors, the recommended course of action may not even be immediate treatment but “active surveillance.” This involves closely monitoring the cancer with regular PSA tests, exams, and occasional biopsies, only initiating treatment if the cancer shows signs of progressing. This approach helps men avoid the potential side effects of treatment for a cancer that may never have threatened their lives.
Myth 5: Treatment Causes Impotence and Incontinence
The fear of treatment side effects, particularly erectile dysfunction (impotence) and urinary incontinence, is one of the biggest deterrents for men considering screening or treatment. While these are indeed potential risks, the myth is that they are inevitable and permanent consequences for every man. This is far from the truth.
Medical and surgical techniques have advanced dramatically. During a radical prostatectomy (surgical removal of the prostate), surgeons can now use nerve-sparing techniques, often with robotic assistance, to carefully work around the delicate nerve bundles that control erections. Similarly, modern radiation therapies, such as Intensity-Modulated Radiation Therapy (IMRT) and proton therapy, can target the prostate with incredible precision, minimizing damage to the surrounding bladder and rectum.
The likelihood of experiencing these side effects depends on many factors, including the man’s age, his function before treatment, the skill of the surgeon or radiation oncologist, and the stage of his cancer. Many men experience temporary issues that improve significantly over time with pelvic floor exercises and, if needed, medications or other therapies. It is crucial for men to have a detailed discussion with their medical team about the specific risks and benefits of each treatment option, including active surveillance, to make a decision that aligns with their health needs and quality-of-life priorities.
Myth 6: Vasectomies and Frequent Ejaculation Affect My Risk
Myths about lifestyle and sexual health are also common. One persistent concern is that having a vasectomy increases the risk of prostate cancer. This idea originated from a few studies in the 1990s that suggested a possible link. However, since then, numerous larger and more robust studies have been conducted, and the overwhelming consensus in the medical community is that there is no conclusive evidence linking vasectomies to an increased risk of developing or dying from prostate cancer.
On the other side of the coin is the myth that frequent ejaculation can cause prostate cancer through “overuse.” The opposite may actually be true. While more research is needed for a definitive conclusion, several large studies have suggested a correlation between a higher frequency of ejaculation and a lower risk of prostate cancer. The theory is that ejaculation may help clear out potentially cancer-causing substances from the prostate. While this should not be considered a proven prevention strategy, it effectively debunks the idea that it is harmful.
Knowledge is Power in Personal Health Management
Myths and misinformation thrive in silence. For too long, prostate cancer has been a subject men avoid, to their own detriment. Dispelling these myths is the first and most critical step toward changing the narrative. Prostate cancer is not just an old man’s disease. The absence of symptoms does not mean the absence of cancer. A high PSA is a warning, not a verdict. A diagnosis is not a death sentence, and treatment does not automatically mean a life without sexual function or bladder control.
By arming themselves with factual information, men can move from a place of fear to a position of power. Understanding the real risks, the importance of early detection, and the full spectrum of modern treatment options allows for informed, proactive decision-making. The path forward is clear: break the silence, ask questions, have open conversations with doctors and family, and encourage others to do the same. In the fight against prostate cancer, knowledge is the most powerful weapon we have.
Comprehensive Cancer Centers Can Help
The medical team at Comprehensive Cancer Centers provides a variety of treatment options for patients with prostate cancer, with all treatments being done in Southern Nevada. To schedule an appointment with the team at Comprehensive, please call 702-952-3350.
The content in this post is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of qualified health providers with questions you may have regarding medical conditions.
